Evidence map›Paper›PMID 38052219›Full record

ReviewDeutsche medizinische Wochenschrift (1946)2023

[Vaccinations as a key to pandemic management - Lessons learned from the COVID-19 pandemic].

Ngoc Han Le, David Hillus, Pinkus Tober-Lau, Leif Erik Sander

Open access · hybridAbstract readReviewEnglish Abstract
In one paragraph

Review in Deutsche medizinische Wochenschrift (1946), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ngoc Han Le
David Hillus
Pinkus Tober-Lau
Leif Erik Sander
Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pandemics and epidemic outbreaks caused by emerging pathogens can usually only be curbed in the longterm through establishment of protective population-wide immunity. With the unprecedented rapid development and supply of highly effective vaccines against COVID-19, science and industry delivered the critical medical breakthrough for the successful management of the COVID-19 pandemic. By May 2023, WHO could end the public health emergency. Nevertheless, the pandemic and its consequences for medicine, science, and society continue to reverberate. This article reviews at the development and implementation of COVID-19 vaccines, focusing on the situation in Germany, and seeks to draw lessons from the past three years to improve our readiness to combat future outbreaks and pandemics more effectively.

Indexed as

COVID-19COVID-19 VaccinesDisease OutbreaksHumansPandemicsVaccinationCOVID-19 Vaccines

Identifiers

PMID38052219
PMCPMC10923633
OpenAlexW4389327787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.